Literature DB >> 21660960

Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation.

Xihong Liu1, Shi Yue, Changyong Li, Lin Yang, Hong You, Liying Li.   

Abstract

The biological roles of sphingosine 1-phosphate (S1P) and S1P receptors (S1PRs) have been broadly investigated. However, at present pathophysiological roles of S1P/S1PRs axis in liver fibrosis are not well defined. Here, we investigated the functions of S1P/S1PRs axis in human hepatic stellate cells (HSC) line, LX-2 cells. We found that S1PR types 1, 2 and 3 (S1PR1-3) are clearly detected in LX-2 cells, as determined by RT-PCR, Western blot and immunocytochemistry analysis. S1P exerted a powerful migratory action on LX-2 cells, as determined in Boyden chambers, and stimulated fibrogenic activity of LX-2 cells, as demonstrated by increase of expression of smooth muscle α-actin, procollagen α1(I) and α1(III) and total hydroxyproline content. Moreover, the effects of S1P were mimicked by S1PR1 agonist SEW2871, and abrogated by W146 (S1PR1 antagonist) and/or silencing S1PR1, three expression with small interfering RNA, suggesting the main roles of S1PR1 and 3. However, studies with S1PR2 antagonist JTE-013 and silencing S1PR2 expression indicated that S1PR2 negatively regulated S1P-induced cell migration. Interestingly, exogenously added S1P induced significant up-regulation of sphingosine kinase-1 and the synthesis of additional S1P, and expression of S1PR1,3, but not S1PR2. In conclusion, our data have identified an additional function regulated by S1P/S1PR1,3 axis involving migration and fibrogenic activation of HSCs. These results suggest that selective modulation of S1PR activity may represent a new antifibrotic strategy.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660960     DOI: 10.1002/jcp.22572

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  20 in total

Review 1.  Lysophospholipid receptor nomenclature review: IUPHAR Review 8.

Authors:  Yasuyuki Kihara; Michael Maceyka; Sarah Spiegel; Jerold Chun
Journal:  Br J Pharmacol       Date:  2014-07-12       Impact factor: 8.739

Review 2.  Review article: the sphingosine 1 phosphate/sphingosine 1 phosphate receptor axis - a unique therapeutic target in inflammatory bowel disease.

Authors:  Jie Wang; Idan Goren; Bo Yang; Sinan Lin; Jiannan Li; Michael Elias; Claudio Fiocchi; Florian Rieder
Journal:  Aliment Pharmacol Ther       Date:  2021-12-21       Impact factor: 8.171

3.  You aren't IMMUNE to the ceramides that accumulate in cardiometabolic disease.

Authors:  Joseph V Varre; William L Holland; Scott A Summers
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-02-23       Impact factor: 5.228

4.  HuR mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis.

Authors:  Na Chang; Jingjing Ge; Lei Xiu; Zhongxin Zhao; Xianghui Duan; Lei Tian; Jieshi Xie; Lin Yang; Liying Li
Journal:  J Mol Med (Berl)       Date:  2016-08-20       Impact factor: 4.599

5.  DES1: A Key Driver of Lipotoxicity in Metabolic Disease.

Authors:  Jeremy T Blitzer; Liping Wang; Scott A Summers
Journal:  DNA Cell Biol       Date:  2020-03-16       Impact factor: 3.311

6.  Sphingolipid regulation of tissue fibrosis.

Authors:  Barry S Shea; Andrew M Tager
Journal:  Open Rheumatol J       Date:  2012-06-15

7.  Sphingosine-1-phosphate/S1P receptors signaling modulates cell migration in human bone marrow-derived mesenchymal stem cells.

Authors:  Yaxian Kong; Hong Wang; Tao Lin; Shuling Wang
Journal:  Mediators Inflamm       Date:  2014-07-23       Impact factor: 4.711

8.  Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice.

Authors:  Sarah Alsamman; Stephanie A Christenson; Amy Yu; Nadia M E Ayad; Meghan S Mooring; Joe M Segal; Jimmy Kuang-Hsien Hu; Johanna R Schaub; Steve S Ho; Vikram Rao; Megan M Marlow; Scott M Turner; Mai Sedki; Lorena Pantano; Sarani Ghoshal; Diego Dos Santos Ferreira; Hsiao-Yen Ma; Caroline C Duwaerts; Regina Espanol-Suner; Lan Wei; Benjamin Newcomb; Izolda Mileva; Daniel Canals; Yusuf A Hannun; Raymond T Chung; Aras N Mattis; Bryan C Fuchs; Andrew M Tager; Dean Yimlamai; Valerie M Weaver; Alan C Mullen; Dean Sheppard; Jennifer Y Chen
Journal:  Sci Transl Med       Date:  2020-08-19       Impact factor: 19.319

9.  Sphingosine 1-Phosphate Receptor 2 and 3 Mediate Bone Marrow-Derived Monocyte/Macrophage Motility in Cholestatic Liver Injury in Mice.

Authors:  Le Yang; Zhen Han; Lei Tian; Ping Mai; Yuanyuan Zhang; Lin Wang; Liying Li
Journal:  Sci Rep       Date:  2015-09-01       Impact factor: 4.379

10.  15-Deoxy-Δ(12,14)-Prostaglandin J2 Inhibits Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury via Redox Pathway.

Authors:  Xin Liu; Shuangshuang Jia; Weiyang Li; Le Yang; Lin Yang; Lin Wang; Liying Li
Journal:  PPAR Res       Date:  2015-09-20       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.